Renal Insufficiency Following Contrast Media Administration Trial III

NAUnknownINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

July 15, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Contrast Nephropathy
Interventions
DEVICE

RenalGuard system™® (PLC Medical Systems, Inc. Franklin, MA, USA)

Patients in the RenalGuard group will be treated by hydration with normal saline controlled by the RenalGuard system™® (PLC Medical Systems, Inc. Franklin, MA, USA). The RenalGuard system includes a) a closed loop fluid management system; b) a high volume fluid pump, c) a high accuracy dual weight measuring system; d) motion detection artifact reduction; e) a single use intravenous set and urine collection system that interfaces with a standard Foley catheter; f) real-time display of urine and replacement fluid volume; g) a timely alerts to drain the urine bag or to replace the hydration fluid bag; f) and safety features such as automatic air and occlusion detection.

Sponsors
All Listed Sponsors
lead

Clinica Mediterranea

OTHER

NCT02489669 - Renal Insufficiency Following Contrast Media Administration Trial III | Biotech Hunter | Biotech Hunter